Skip to main content

Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market cagr 13.8%

Page 1


Enzyme-Linked Immunosorbent Assay (Elisa)

Testing Market

Enzyme-Linked Immunosorbent Assay (Elisa)

Testing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Enzyme-Linked Immunosorbent Assay (Elisa) Testing

Market Size and Growth

The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is experiencing significant growth, driven by increasing demand for diagnostic tools and advancements in technology. The market size is projected to reach approximately $4 billion by 2025, reflecting expanded applications in clinical diagnostics, research, and biotechnology, alongside rising healthcare expenditure globally.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Ortho-Clinical Diagnostics, Inc.

◍ Thermo Fisher Scientific. Inc.

◍ Life Technologies Corporation

◍ ZEUS Scientific, Inc.

◍ R & D Systems (a Biotechne brand)

◍ Abbexa

◍ Abcam

◍ Abelisa

◍ Abnova

◍ Bhat Bio-tech

◍ Bio-Rad Laboratories

◍ Biorbyt

◍ Calbiotech

◍ Cayman Chemicals

◍ Crystal Chem

◍ Diagenics

◍ Eagle Biosciences

The Enzyme-Linked Immunosorbent Assay (ELISA) testing market features key players like Thermo Fisher Scientific and Bio-Rad Laboratories, focusing on innovative assay kits and instruments. These companies enhance market growth through product development, strategic partnerships, and amplifying laboratory capabilities. Specific revenues are not provided due to confidentiality constraints.

Request Sample Report

Market Segmentation

By Application

◍ Immunology

◍ Inflammation

◍ Infectious diseases

◍ Cancer

◍ Protein quantitation

◍ Other

By Product

◍ Sandwich ELISA

◍ Indirect ELISA

◍ Multiple and portable ELISA

◍ Competitive ELISA

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market cagr 13.8% by ReportPrime - Issuu